Risankizumab,Ixekizumab,Secukinumab
abbvie,eli lilly,novartis,Boehringer Ingelheim
['taltz', 'skyrizi', 'cosentyx', 'abbvie']
#aad2023 - #abbvie presented efficacy data of #skyrizi in patients with inadequate response to #cosentyx and #taltz. #pharma #pharmaceutical #healthcare #globalhealth #patientcare #news #media #medicine #digitalhealth #publichealth #aad23 #aad #conferences
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma